Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction

Details for Australian Patent Application No. 2006206454 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Israel, Robert J.

Agent Davies Collison Cave

Pub. Number AU-A-2006206454

PCT Pub. Number WO2006/078842

Priority 60/645,652 20.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 1/10 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/078842 Priority application(s): WO2006/078842

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206456-Water-soluble film article having salt layer, and method of making the same

2006206446-Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors